BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26790728)

  • 1. Apolipoprotein E polymorphism modulation of asymmetric dimethylarginine in hypertensive patients is determined by renal function.
    Marrocos MS; Teixeira AA; Quinto BM; Carmona Sde M; Kuniyoshi M; Rodrigues CJ; Dalboni MA; Manfredi S; Canziani ME; Batista MC
    Lipids Health Dis; 2016 Jan; 15():14. PubMed ID: 26790728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic renal impairment and DDAH2-1151 A/C polymorphism determine ADMA levels in type 2 diabetic subjects.
    Marra M; Marchegiani F; Ceriello A; Sirolla C; Boemi M; Franceschi C; Spazzafumo L; Testa I; Bonfigli AR; Cucchi M; Testa R
    Nephrol Dial Transplant; 2013 Apr; 28(4):964-71. PubMed ID: 23129820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.
    Betz B; Möller-Ehrlich K; Kress T; Kniepert J; Schwedhelm E; Böger RH; Wanner C; Sauvant C; Schneider R
    Transl Res; 2013 Aug; 162(2):67-76. PubMed ID: 23707198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
    Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
    Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
    Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
    Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of apolipoprotein E genetic variation in Alzheimer's disease in Indian population: a meta-analysis.
    Agarwal R; Tripathi CB
    Am J Alzheimers Dis Other Demen; 2014 Nov; 29(7):575-82. PubMed ID: 25551132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diversity of apolipoprotein E genetic polymorphism significance on cardiovascular risk is determined by the presence of metabolic syndrome among hypertensive patients.
    Teixeira AA; Marrocos MS; Quinto BM; Dalboni MA; Rodrigues CJ; Carmona Sde M; Kuniyoshi M; Batista MC
    Lipids Health Dis; 2014 Nov; 13():174. PubMed ID: 25413697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Polymorphisms Ser447Ter of lipoprotein-lipase gene, Cys112Arg and Arg158Cys of apolipoprotein E gene in patients with obesity].
    Kirillova OO; Vorozhko IV; Gapparova KM; Chekhonina IuG; Sentsova TB; Tutel'ian VA
    Vopr Pitan; 2013; 82(4):4-9. PubMed ID: 24340925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E genotypes and their relation to lipid levels in a rural South African population.
    Masemola ML; Alberts M; Urdal P
    Scand J Public Health Suppl; 2007 Aug; 69():60-5. PubMed ID: 17676504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of apolipoprotein E polymorphism and concentration with serum lipids and apolipoprotein level in the Chinese from Shanghai.
    Shen X; Xia Y; Sass C; Visvikis S; Siest G
    Clin Chem Lab Med; 1998 Aug; 36(8):615-9. PubMed ID: 9806471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Putative role of asymmetric dimethylarginine in microvascular disease of kidney and heart in hypertensive patients.
    Fujii H; Takiuchi S; Kawano Y; Fukagawa M
    Am J Hypertens; 2008 Jun; 21(6):650-6. PubMed ID: 18443575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E gene polymorphisms are associated with carotid plaque formation but not with intima-media wall thickening: results from the Perth Carotid Ultrasound Disease Assessment Study (CUDAS).
    Beilby JP; Hunt CC; Palmer LJ; Chapman CM; Burley JP; McQuillan BM; Thompson PL; Hung J;
    Stroke; 2003 Apr; 34(4):869-74. PubMed ID: 12637699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid profile and apolipoprotein E polymorphism in essential hypertension.
    Bhavani AB; Sastry KB; Reddy NK; Padma T
    Indian Heart J; 2005; 57(2):151-7. PubMed ID: 16013355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of apolipoprotein-E polymorphism and plasma lipid levels in dyslipidemic and asymptomatic subjects, and their implication in cardio/cerebro-vascular disorders.
    Ferreira CN; Carvalho MG; Fernandes AP; Lima LM; Loures-Valle AA; Dantas J; Janka Z; Palotás A; Sousa MO
    Neurochem Int; 2010 Jan; 56(1):177-82. PubMed ID: 19819279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of asymmetric dimethylarginine on atherogenesis and erythrocyte deformability in apolipoprotein E deficient mice.
    Xiao HB; Yang ZC; Jia SJ; Li NS; Jiang DJ; Zhang XH; Guo R; Zhou Z; Deng HW; Li YJ
    Life Sci; 2007 Jun; 81(1):1-7. PubMed ID: 17532008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between Apolipoprotein E Gene Polymorphisms and Cardiovascular Complications of Uremic Patients on Maintenance Hemodialysis.
    Zheng CZ; Qi XM; Shu YB; Bai YW; Wu YG
    Blood Purif; 2018; 46(1):48-55. PubMed ID: 29672279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced renal plasma clearance does not explain increased plasma asymmetric dimethylarginine in hypertensive subjects with mild to moderate renal insufficiency.
    Ronden RA; Houben AJ; Teerlink T; Bakker JA; Bierau J; Stehouwer CD; De Leeuw PW; Kroon AA
    Am J Physiol Renal Physiol; 2012 Jul; 303(1):F149-56. PubMed ID: 22552932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
    Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
    Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E polymorphism in the Tunisian population: frequency and effect on lipid parameters.
    Jemaa R; Elasmi M; Naouali C; Feki M; Kallel A; Souissi M; Sanhaji H; Hadj Taïeb S; Souheil O; Kaabachi N
    Clin Biochem; 2006 Aug; 39(8):816-20. PubMed ID: 16714010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA.
    Sydow K; Hornig B; Arakawa N; Bode-Böger SM; Tsikas D; Münzel T; Böger RH
    Vasc Med; 2004 May; 9(2):93-101. PubMed ID: 15521698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.